Pharma Commons
  • Home
  • About
  • Company List
  • Contact

Pfizer grants ChemRar Group exclusive license to DPP-IVi T2D candidate

July 6, 2012 CenterWatch News Online Headlines Pfizer
Pfizer has granted SatRx, a company belonging to Russian pharmaceutical investment and R&D group ChemRar Hi-Tech Centre, exclusive development and marketing rights to for its DPP(1)-IVi…
Read the full story: CenterWatch News Online Headlines

Post navigation

Pfizer inks licensing deal with Russia’s SatRx for diabetes drug
Roche receives FDA approval for cytomegalovirus viral load test

Receive a daily news digest

Enter your email address:

Search the archive

Search for:

Company list

Browse by tags

Abbott abbott laboratories Amgen astrazeneca astrazeneca plc Bayer biogen idec boehringer ingelheim breast cancer bristol myers bristol myers squibb bristol myers squibb company cancer drug diabetes drug eli lilly eli lilly and company food and drug administration genepool gilead sciences gilead sciences inc glaxosmithkline glaxosmithkline plc gsk latest biotech news Lilly lilly and company london reuters Merck merck kgaa merck serono Myers Nordisk Novartis novartis ag novo nordisk pfizer pfizer inc Pharma PLC PRNewswire reuters Roche roche holding ag rsquo sanofi
dazzling Theme by Colorlib Powered by WordPress